The
Sheath Dilators Market research report thoroughly explains each and every aspect related to the Global Sheath Dilators Market, which facilitates the report’s reader to study and evaluate the upcoming market trend and execute the analytical data to promote the business.
Sheath Dilators Market Insight:
Sheath dilators market is expected to witness market expansion at 6.90% in the forecast period of 2020 to 2027. With the market expected to reach this valuation, there have been a number of factors behind this market expansion such as the preference of patients and physicians alike on undertaking minimally invasive procedures such as percutaneous nephrostomy (PCN) procedure.
10
Sheath Dilators Market Research Report conducts a deep estimation of the present state of the Sheath Dilators Industry with the definition, classification, and market scope. The data included in the report has been generated by consulting industry leaders and taking inputs from them. The topmost subdivisions of the market have been emphasized and these divisions have been presented by giving statistics on their current state by the end of the forecast horizon.
Sheath Dilators Market Insight:
Sheath dilators market is expected to witness market expansion at 6.90% in the forecast period of 2020 to 2027. With the market expected to reach this valuation, there have been a number of factors behind this market expansion such as the preference of patients and physicians alike on undertaking minimally invasive procedures such as percutaneous nephrostomy (PCN) procedure.
2-French Electrophysiology Microcatheter Launches in Europe, Enabling Deeper Coronary Sinus Mapping
TORONTO, Jan. 19, 2021 /PRNewswire/ Baylis Medical announced today the launch and first clinical case in Europe of the JLL 2-French electrophysiology microcatheter, performed by Dr. Thomas Deneke at Heart Center, Bad Neustadt, Germany. The launch enables physicians to reach previously inaccessible areas of the heart for procedure mapping, by making available the smallest diagnostic catheter in the European electrophysiology market.
The JLL electrophysiology catheter family includes a 2F microcatheter and a 6F guiding catheter which can be combined to allow deeper coronary sinus (CS) mapping. Deeper electrophysiological examination, including mapping, is often required to aid in the diagnosis of idiopathic ventricular tachycardias, complex atrial tachycardias, and left Wolff-Parkinson-White Syndrome. The 2F microcatheter also allows mapping and pacing in smaller anatomy such as the
Share this article
Share this article
NEW YORK, Jan. 18, 2021 /PRNewswire/ With advancements in the healthcare industry, the preference for minimally invasive surgeries (MIS) is increasing. This factor is projected to drive the global radiofrequency ablation devices market at a healthy 12.6% CAGR between 2020 and 2030. At this rate, the revenue generated by market players will rise from $3,173.5 million in 2019 to $11,080.3 million in 2030, according to P&S Intelligence.
The rising popularity of MISs is driving the radiofrequency ablation devices market as RFA is becoming the preferred MIS procedure for pain management and numerous cardiac diseases. RFA is also being increasingly used for the treatment of bone diseases, cancer, and pain in the back, neck, sacroiliac joint, and facet joints. Such minimally invasive procedures offer quick and long-lasting relief and reduce the risk of open-surgery-associated infections and complications.
Published: Dec 15, 2020
TORONTO, Dec. 15, 2020 /CNW/ -
Baylis Medical announced today the Canadian launch of its EPstar Electrophysiology Catheters. The launch enables physicians to reach previously inaccessible areas of the heart for procedure mapping, by making available the smallest diagnostic catheter in the Canadian electrophysiology market.
The EPstar catheter family includes a 2F catheter and a 6F guiding catheter which can be combined to allow deeper coronary sinus (CS) mapping. Deeper electrophysiological examination, including mapping, is often required to aid in the diagnosis of idiopathic ventricular tachycardias, complex atrial tachycardias, and left Wolff-Parkinson-White Syndrome. The 2F catheter also allows mapping and pacing in smaller anatomy such as the Vein of Marshall (VOM).